(Q44039631)

29 November 2017

title

Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study (English)

1 reference

29 November 2017

Carlos Iribarren

1

1 reference

29 November 2017

Alfred D Round

2

1 reference

29 November 2017

Jonathan A Peng

3

1 reference

29 November 2017

Meng Lu

4

1 reference

29 November 2017

Jonathan G Zaroff

5

1 reference

29 November 2017

Taylor J Holve

6

1 reference

29 November 2017

Amit Prasad

7

1 reference

29 November 2017

Paul Stang

8

1 reference

29 November 2017

publication date

16 July 2013

1 reference

Pharmacoepidemiology and Drug Safety

29 November 2017

published in

1 reference

29 November 2017

volume

22

1 reference

29 November 2017

issue

11

1 reference

29 November 2017

page(s)

1222-1232

1 reference

QT interval variables from 24 hour electrocardiography and the two year risk of sudden death

29 November 2017

cites work

1 reference

Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutation

21 January 2018

1 reference

Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance

21 January 2018

1 reference

Drug-induced prolongation of the QT interval

21 January 2018

1 reference

Short QT Syndrome: a familial cause of sudden death

21 January 2018

1 reference

21 January 2018

1 reference

Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients

21 January 2018

1 reference

Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology

21 January 2018

1 reference

Relation of QT interval measurements to evolving automated algorithms from different manufacturers of electrocardiographs

21 January 2018

1 reference

Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval

21 January 2018

1 reference

AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhyth

21 January 2018

1 reference

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

21 January 2018

1 reference

Relative incidence estimation from case series for vaccine safety evaluation.

21 January 2018

1 reference

Two cases of short QT interval.

21 January 2018

1 reference

New prescription medication gaps: a comprehensive measure of adherence to new prescriptions

21 January 2018

1 reference

Possible interethnic differences in quinidine-induced QT prolongation between healthy Caucasian and Korean subjects

21 January 2018

1 reference

The significance of QT interval in drug development

21 January 2018

1 reference

Intravenous antiarrhythmic regimens with focus on amiodarone for prophylaxis of atrial fibrillation after open heart surgery

21 January 2018

1 reference

Clinical efficacy of amiodarone as an antiarrhythmic agent

21 January 2018

1 reference

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

21 January 2018

1 reference

Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs

21 January 2018

1 reference

Arrhythmogenic mechanisms of non-sedating antihistamines

21 January 2018

1 reference

Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder

21 January 2018

1 reference

Psychotropic drugs associated with corrected QT interval prolongation

21 January 2018

1 reference

Tricyclic antidepressants, QT interval prolongation, and torsade de pointes

21 January 2018

1 reference

Doxepin-induced torsade de pointes tachycardia

21 January 2018

1 reference

Association of antipsychotic and antidepressant drugs with Q-T interval prolongation

21 January 2018

1 reference

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death

21 January 2018

1 reference

Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder

21 January 2018

1 reference

Cardiac toxicity from phenylpropanolamine overdose in a dog.

21 January 2018

1 reference

Phenylpropanolamine and the risk of hemorrhagic stroke

21 January 2018

1 reference

Valvular heart disease associated with fenfluramine-phentermine

21 January 2018

1 reference

Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals

21 January 2018

1 reference

Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases

21 January 2018

1 reference

Itraconazole-induced torsade de pointes in a patient receiving methadone substitution therapy

21 January 2018

1 reference

Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation

21 January 2018

1 reference

Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

21 January 2018

1 reference

The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.

21 January 2018

1 reference

Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions

21 January 2018

1 reference

A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.

21 January 2018

1 reference

Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.

21 January 2018

1 reference

Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.

21 January 2018

1 reference

QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France

21 January 2018

1 reference

QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system

21 January 2018

1 reference

Effects of quinidine versus procainamide on the QT interval

21 January 2018

1 reference

Prolonged QT interval, syncope, and delirium with galantamine

21 January 2018

1 reference

Autonomic nervous system influences on QT interval in normal subjects

21 January 2018

1 reference

Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events.

21 January 2018

1 reference

Genome-wide association study of antipsychotic-induced QTc interval prolongation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.3479

1 reference

29 November 2017

1 reference